Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1832588 (
PSS
)
2,979
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gold nanoparticles of 5 nm diameter, stabilized by 4-(dimethylamino)pyridine (
DMAP
), were coated with poly(sodium 4-styrene sulfonate) (
PSS
) via electrostatic self-assembly. The suspension stability, monitored by the gold surface plasmon band (SPB), was studied by varying the pH, the
PSS
chain length, and
PSS
concentration. Enhanced stability is obtained at pH 10 (above the pKa of
DMAP
) when the polymer chain length matches or exceeds the particle circumference. Solid state 13C NMR was used to determine the presence of
DMAP
and polymers after subsequent deposition of weak and strong polycations: poly(allylamine hydrochloride) (PAH) and poly(diallyldimethylammonium chloride) (PDADMAC). At pH 10,
DMAP
remains associated with the nanoparticle after the first
PSS
layer has been formed. When PAH or PDADMAC are subsequently added at pH 4.5,
DMAP
is expelled, the suspensions remain stable, and zeta potential values indicate complete charge reversal. In the case of PDADMAC, however, the first layer of
PSS
is not fully retained. When PDADMAC is added at pH 10,
DMAP
and the first
PSS
layer are retained but lower zeta potentials and a higher SPB shift indicate a degraded stability. For PAH addition at pH 9.5, both
DMAP
and
PSS
are expelled and the suspension becomes unstable. These differences in stability of the multilayer components and the nanoparticle suspension are rationalized in terms of chain flexibility, polymer charge density, and the ability of the polymer functional groups to directly interact with the gold surface.
...
PMID:Preparation and characterization of polyelectrolyte-coated gold nanoparticles. 1822 59